Axis Mutual Fund trimmed its stake in Divi's Laboratories from 1.38% to 1.36%, selling 63,746 shares.
A leading manufacturer and exporter of active pharmaceutical ingredients, intermediates, and nutraceutical ingredients serving global pharmaceutical and healthcare markets. Incorporated in 1990, the company operates across multiple therapeutic segments with vertically integrated manufacturing infrastructure. It distinguishes itself through expertise in complex chemistry, stringent quality standards, and a diversified product portfolio catering to customers worldwide.
Subsidiary of Axis Bank, India's third-largest private sector bank. Manages over Rs 3.5 lakh crore in AUM. Built its brand on a quality growth equity philosophy with concentrated high-conviction portfolios. Flagship Axis Flexi Cap and Axis Bluechip funds are widely held among retail investors and drove significant AUM growth through the 2017-2021 bull cycle.
